Sign In
Buy HSIC
$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders
07:00am, Wednesday, 08'th Apr 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to r
Williams, Henry Schein, and 3 Other Bargain Stocks From a Veteran Value Fund Manager
03:08pm, Tuesday, 07'th Apr 2026
Ari Sass of the M.D. Sass Concentrated Value ETF is hunting for reasonably priced growth stocks like Henry Schein.
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of “Hold” from Brokerages
02:38am, Monday, 06'th Apr 2026
Shares of Henry Schein, Inc. (NASDAQ: HSIC - Get Free Report) have received a consensus recommendation of "Hold" from the thirteen brokerages that are currently covering the stock, MarketBeat.com repo
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 31'st Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound?
12:32pm, Thursday, 26'th Mar 2026
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Should You Retain Henry Schein Stock in Your Portfolio for Now?
09:16am, Thursday, 26'th Mar 2026
HSIC's growth from its Henry Schein One venture and partnerships is promising, but macro pressures and stiff competition raise concerns for investors.
Here's Why Henry Schein (HSIC) is a Strong Growth Stock
10:46am, Wednesday, 18'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies® for 15th Consecutive Year
06:30am, Wednesday, 18'th Mar 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, has been recognized as one of
Analyzing Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC)
01:42am, Sunday, 15'th Mar 2026
Cooper Companies (NASDAQ: COO - Get Free Report) and Henry Schein (NASDAQ: HSIC - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses
Henry Schein: Still A Buy - But Caution Is Warranted
10:17am, Thursday, 12'th Mar 2026
Henry Schein, Inc. is rated a 'Buy' as signs of improving growth and undervaluation emerge despite recent stagnation. HSIC's recent results show solid revenue and EPS growth, but operating margins and
Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
04:30pm, Tuesday, 10'th Mar 2026
Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Henry Schein One Unveils the Next Era of Dentrix Ascend for DSOs and Growth-Focused Practices
06:30am, Tuesday, 10'th Mar 2026
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the market leader in dental practice management systems, today unveiled the next era of Dentrix Ascend—introducing three new packages built on
Dimensional Fund Advisors LP Boosts Stake in Henry Schein, Inc. $HSIC
04:38am, Tuesday, 10'th Mar 2026
Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein, Inc. (NASDAQ: HSIC) by 6.5% during the third quarter, according to its most recent disclosure with the Securities and Exc
Henry Schein, Inc. (HSIC) Presents at Leerink Global Healthcare Conference 2026 Transcript
12:37pm, Monday, 09'th Mar 2026
Henry Schein, Inc. (HSIC) Presents at Leerink Global Healthcare Conference 2026 Transcript
Here's Why Henry Schein (HSIC) is a Strong Value Stock
10:40am, Thursday, 05'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
